These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 7528385)
1. The assessment of medical treatment for benign prostatic hyperplasia (BPH). Roehrborn CG Prog Clin Biol Res; 1994; 386():175-90. PubMed ID: 7528385 [No Abstract] [Full Text] [Related]
2. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Kaplan SA J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031 [No Abstract] [Full Text] [Related]
4. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359 [TBL] [Abstract][Full Text] [Related]
5. Medical management of benign prostatic hyperplasia other than with hormones or alpha blockers. Fitzpatrick JM; Dreikorn K; Habib F; Mebust WK; Perrin P; Schulze HK Prog Clin Biol Res; 1994; 386():303-9. PubMed ID: 7528399 [No Abstract] [Full Text] [Related]
6. Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia. Mensink HJ Prog Clin Biol Res; 1994; 386():285-9. PubMed ID: 7528396 [No Abstract] [Full Text] [Related]
7. Treatment options in benign prostatic hypertrophy. Stone NN Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248 [TBL] [Abstract][Full Text] [Related]
8. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia]. Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182 [No Abstract] [Full Text] [Related]
9. [A clinical trial of the treatment of patients with benign prostatic hyperplasia using the alpha 1-adrenoblocker alfuzosin]. Lopatkin NA; Perepanova TS Urol Nefrol (Mosk); 1997; (5):14-6. PubMed ID: 9412005 [TBL] [Abstract][Full Text] [Related]
14. [Current drug therapy of benign prostatic hyperplasia]. Schmidbauer CP; Madersbacher S Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400 [TBL] [Abstract][Full Text] [Related]
15. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study]. Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599 [No Abstract] [Full Text] [Related]
16. [Non-surgical treatment of benign prostatic hypertrophy]. Martini E; Vaggi L; Rucci A; Di Clemente L J Chir (Paris); 1994 Oct; 131(10):445-9. PubMed ID: 7532181 [No Abstract] [Full Text] [Related]
17. [Non-surgical treatment of prostatic hyperplasia]. Srougi M AMB Rev Assoc Med Bras; 1990; 36(1):11-4. PubMed ID: 1705045 [No Abstract] [Full Text] [Related]
18. Medical management of benign prostatic hyperplasia: a review. Magoha GA East Afr Med J; 1996 Jul; 73(7):453-6. PubMed ID: 8918007 [TBL] [Abstract][Full Text] [Related]